What is the National Prostate Cancer (NPCA) Patient Survey?
Men with localised prostate cancer who receive radical surgical or radiotherapy treatments usually survive for many years with the potential side effects of these treatments including urinary, bowel and sexual dysfunction. The NPCA Patient Survey is designed to determine patients’ views of their experience of care and outcomes following diagnosis and treatment.
Patients are asked questions about their quality of life, side effects, sexual/urinary/bowel complications, the information they received about their prostate cancer diagnosis and treatment options, and how the decision about their initial treatment was made.
Why have I been invited to participate?
Men who were diagnosed with prostate cancer between the 1st April 2014 and 30th September 2016 in England and the 1st April 2015 and 30th September 2016 in Wales are being sent a questionnaire at least 18 months after diagnosis. This includes men who underwent radical surgical or radiotherapy treatments, in addition to those men who are being closely monitored for disease progression.
More information about the NPCA Patient Survey can be found here:
Update from the NPCA team, March 2018:
We would like to thank all men who have completed the NPCA survey to date resulting in an impressive average response rate of 74% (patients diagnosed between April 2014 – March 2016). The results from this survey provide a unique insight on the quality of care received and the impact of radical treatment on daily lives.
The first anonymised results were published in the NPCA Annual Report 2016. A patient summary was published in March 2017. With your help, we look forward to building further this important work as the audit continues.